PDP1 and type 2 diabetes mellitus: In line with this, we have recently shown that by pharmacologically increasing PDH flux, and therefore rebalancing glucose utilization, it is possible to reverse the diastolic impairment observable in a rodent model of T2DM.7 This highlights the importance of PDH in this process as a potential therapeutic target.